Abstract
A method is developed to electrochemically induce target-specific covalent capturing of the spike protein of SARS-Cov-2, forming a covalent peptide-protein complex fit for working with such complicated clinical samples. Specifically, peptide-coordinated copper ions can be electrochemically controlled to induce cross-linkage between certain amino acids on the peptide probe and the target protein. Therefore, target specificity can be tuned electrochemically, realizing highly specific targeting of the omicron S protein or broader specificity toward all variants of the virus. Using this method, with electrochemically catalyzed generation of signal-enhancing molecules, the sensitivity and covalent detection allow their application in both serum and fecal samples. These results may point to their possible use in screening new variants of the virus in the near future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
